Please note the newsletter is in French only.
Newsletters
April 10, 2024
April 2024 Newsletter
More News
& publications
Feldan Therapeutics partners with TransBIOTech on NSERC funded project to accelerate development of innovative intralesional treatments
Feldan Therapeutics (“Feldan”), a clinical-stage biotech company specializing in the development of therapies based on…
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
CSL Seqirus will supply millions of doses of adjuvanted cell-based vaccine to support Canadians, in the event…
For Quebec public procurement based on value, innovation, and performance
BIOQuébec publishes a position statement on the evolution of procurement practices in…
